Argatroban (Sandoz Inc)
Welcome to the PulseAid listing for the Argatroban drug offered from Sandoz Inc. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Argatroban |
SUBSTANCE NAME: | ARGATROBAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-05-09 |
END MARKETING DATE: | 0000-00-00 |
Argatroban HUMAN PRESCRIPTION DRUG Details:
Item Description | Argatroban from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/125mL) |
START MARKETING DATE: | 2011-05-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-3285_1ae496ee-dc66-4bc0-9676-f8c47f7044e6 |
PRODUCT NDC: | 0781-3285 |
APPLICATION NUMBER: | NDA022485 |
Other ARGATROBAN Pharmaceutical Manufacturers / Labelers: